Articles of interest to a medical doctor with interests in Psychiatry, Technology and Ophthalmology.
28 October, 2016
New drug for severe eczema is successful in two Phase 3 clinical trials: nearly 40% of patients receiving the drug - dupilumab, a monoclonal antibody inhibiting IL4 and IL13 signaling - had complete or near complete remission of symptoms.
No comments:
Post a Comment